NCT00654329View on ClinicalTrials.gov

Dexmedetomidine vs Fentanyl for BMT

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Otitis
Interventions
DRUG

Saline

Normal saline, given intranasally

DRUG

Fentanyl

Fentanyl, nasal transmucosal, 2 micrograms/kilogram

DRUG

Dexmedetomidine

Dexmedetomidine, transmucosal, 1 microgram/kilogram

DRUG

Dexmedetomidine

Dexmedetomidine, 2 microgram/kilogram, transmucosal route

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Children's National Research Institute

OTHER